Sign inGet started

MPM BIOVENTURES III-QP L.P.

Insider CIK 1173409 · KBIO 10% owner · SOMX 10% owner · RDUS 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RDUS Radius Health, Inc. J Other2016-09-272016-09-291,229,902— $02,459,804SEC↗
RDUS Radius Health, Inc. C Conversion deriv2014-06-062014-06-10269,724— $00SEC↗
RDUS Radius Health, Inc. C Conversion deriv2014-06-062014-06-1091,175— $00SEC↗
RDUS Radius Health, Inc. C Conversion deriv2014-06-062014-06-1053,331— $00SEC↗
RDUS Radius Health, Inc. C Conversion deriv2014-06-062014-06-10217,873— $00SEC↗
RDUS Radius Health, Inc. C Conversion2014-06-062014-06-10255,881— $02,595,366SEC↗
RDUS Radius Health, Inc. C Conversion2014-06-062014-06-10399,891— $02,995,257SEC↗
RDUS Radius Health, Inc. J Other2014-06-062014-06-10694,449— $03,689,706SEC↗
RDUS Radius Health, Inc. C Conversion2014-06-062014-06-101,045,351— $02,339,485SEC↗
RDUS Radius Health, Inc. C Conversion2014-06-062014-06-101,294,134— $01,294,134SEC↗
RDUS Radius Health, Inc. P Buy deriv2013-04-232013-04-3091,175$61.42 $5.60M91,175SEC↗
RDUS Radius Health, Inc. P Buy deriv2013-04-232013-04-30227,939$6.14 $1.40M227,939SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion deriv2013-02-052013-02-071,949,879— $00SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion deriv2013-02-052013-02-07337,622— $00SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion deriv2013-02-052013-02-07275,539— $00SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion deriv2013-02-052013-02-071,949,879— $00SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion deriv2013-02-052013-02-07275,539— $00SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion deriv2013-02-052013-02-07337,622— $00SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion2013-02-052013-02-07313,527— $02,632,928SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion2013-02-052013-02-07369,522— $02,319,401SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion2013-02-052013-02-071,949,879— $01,949,879SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion2013-02-052013-02-07313,527— $02,632,928SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion2013-02-052013-02-07369,522— $02,319,401SEC↗
KBIO KALOBIOS PHARMACEUTICALS I C Conversion2013-02-052013-02-071,949,879— $01,949,879SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-07-092012-07-101,624,574$0.31 $503.6K1,275,886SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-07-062012-07-10671,217$0.29 $194.7K2,900,460SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-07-022012-07-0598,210$0.29 $28.5K3,571,677SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-07-022012-07-0580,348$0.29 $23.3K3,669,887SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-06-282012-07-0219,500$0.29 $5.7K3,750,235SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-06-192012-06-2112,000$0.29 $3.5K3,769,735SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-06-152012-06-191,450$0.29 $4203,781,735SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-06-062012-06-078,400$0.29 $2.4K3,783,185SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-06-052012-06-0729,555$0.29 $8.6K3,791,585SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-05-312012-06-0429,850$0.30 $9.0K3,821,140SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-05-302012-06-0451,007$0.30 $15.3K3,850,990SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-05-292012-06-0415,300$0.30 $4.6K3,901,997SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-05-252012-06-04293,015$0.30 $87.9K3,917,297SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-05-232012-06-04135,250$0.30 $40.6K4,210,312SEC↗
SOMX Somaxon Pharmaceuticals, I S Sale2012-05-222012-06-04287,000$0.30 $86.1K4,345,562SEC↗